about
Early prediction of preeclampsiaNatural killer cells and their activation status in normal pregnancy.IONA test for first-trimester detection of trisomies 21, 18 and 13.First-trimester maternal factors and biomarker screening for preeclampsia.The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta-analysis.ASPRE trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE).Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome.Birth weight in live births and stillbirths.Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks.Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks.Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history.Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia.Combined screening for preeclampsia and small for gestational age at 11-13 weeks.C-reactive protein at 11-13 weeks' gestation in spontaneous early preterm delivery.Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.Maternal thyroid function at gestational weeks 11-13 in twin pregnancies.Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks' gestation.First trimester urinary placental growth factor and development of pre-eclampsia.Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management.First trimester prediction of HELLP syndrome.Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.Cervical length and maternal factors in expectantly managed prolonged pregnancy: prediction of onset of labor and mode of delivery.Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.Maternal cardiac function at 35-37 weeks' gestation: relationship with birth weight.Inter-arm blood pressure differences in pregnant women.ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm.Cervical cerclage for preterm birth prevention in twin gestation with short cervix: a retrospective cohort study.Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.ASPRE trial: performance of screening for preterm pre-eclampsia.Body mass index at 11-13 weeks' gestation and pregnancy complications in a Southern Chinese population: a retrospective cohort study.Umbilical and fetal middle cerebral artery Doppler at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.Second-trimester uterine artery Doppler in the prediction of stillbirths.Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.Prediction of labor outcome using serial transperineal ultrasound in the first stage of labor.The transverse technique; a complementary approach to the measurement of first-trimester uterine artery Doppler.
P50
Q34022344-A3971EA3-3A47-4B31-B9D3-012D17F0CB4EQ35100173-B2655AB2-E61A-4131-A02E-8D2793FB0877Q37340438-E64DB176-2BE4-45B6-99AD-A6341FE1E128Q38207000-8002AC22-B2B2-446C-AC7E-D737EAB66B39Q38579259-38019C34-7F3D-42E6-9C13-2F31BA85AC61Q38636397-570814A1-B607-4AF1-AA7C-C6C220562C80Q38906644-7578C4C8-5ABF-42DA-95A8-1D1544D68ECBQ39368300-BD6EC923-A842-4FFC-8608-83609690850DQ40472327-3CD8EC30-021F-439A-9F3C-B3398581C380Q40617657-4FA11B20-3177-41F0-9A41-96D413D482C6Q41204847-E1292098-B0D3-4353-B172-9C0D3C702E40Q41587580-B0A0AAFE-D6A9-459E-B7D0-9B57E4FF39F1Q41593340-5482E0CE-99A1-4134-AD88-FEB2044E1C20Q43718545-C4BC2CDD-A199-42CA-8F58-C12EDD7EB788Q43823700-093BE34A-83E6-4B9A-8423-F06B529967FBQ44197051-3BE1E382-BF9C-4D2D-BC1A-4BB850DD0A52Q45782437-EC31579D-B6EF-4C91-9F3F-B4B4D85F3FA1Q45836564-DA5E082D-EE0E-49B3-B73F-FECBDFE5CC06Q45880396-8E8158AD-30A5-47B3-8CA7-736C8AA24FD9Q46120674-314065C5-5E7F-4303-8BB4-1C3EFE717331Q46149281-D93DCE7A-634C-433D-8130-387D438C534AQ46169022-53A58C86-8E5F-4F5D-908B-EE997DB7C290Q46325836-4CA37D21-7805-441A-92A8-1ABCF48403AEQ46505791-227C1C0B-4AD6-4334-B306-12DB2967ED73Q46912448-74EE94FC-A783-48EE-A2C2-7D1CFA59B5D0Q46955720-079C5720-05E3-4D98-A6E8-B14EED1E7E9CQ47269630-DF0A6529-79D6-473A-AD18-509CE9091E3CQ47390453-BD66418C-94C0-4715-AAA5-553C206346ECQ47554906-F7987BEC-D5E8-41D0-B444-1FA41B0E8280Q47645734-01C8B35C-B914-488D-9DA3-090D43A20B29Q47692938-76D6A120-4E67-4F82-BA8D-683A9F698171Q47752807-D1CA0FB8-7D41-4CED-B34D-076AFFFDA5EDQ47798168-4405F08E-4176-4FBF-8844-94DC700DBB35Q47816750-BC860431-F2C4-491C-87E8-C8249D617EECQ47817199-7DF06C5E-98C3-43F0-8775-840F90658559Q47831509-C5EBCFB9-3EDC-470F-A546-F239CE7C1C7EQ47929307-E45BBD4F-A4F5-47D0-8D41-2B1A2FE08011Q48017621-C3C9B08D-36FE-4EDB-82B1-13DD14BDBDFDQ48217903-B36262F9-3D16-447B-B779-22761BABB0AFQ48246314-7D92D6C7-A17A-4FB2-A3B6-293E26B99E43
P50
description
researcher ORCID ID = 0000-0002-3944-4130
@en
wetenschapper
@nl
name
L Poon
@ast
L Poon
@en
L Poon
@nl
type
label
L Poon
@ast
L Poon
@en
L Poon
@nl
prefLabel
L Poon
@ast
L Poon
@en
L Poon
@nl
P31
P496
0000-0002-3944-4130